文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

1.5 T MR-Linac上前列腺立体定向体部放疗的自动计划

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac.
PubMed 文献 · Adv Radiat Oncol · 2022-02-12

本研究在1.5 T MR-Linac平台上,对10例接受35 Gy/5次前列腺癌SBRT患者的50个每日MRI自适应计划进行离线重新优化,比较专家手动计划与全自动mCycle计划。mCycle计划在靶区覆盖和直肠剂量保护上更优,但机器跳数增加17%、出束时间增加9%,优化时间缩短19%。

要点

  • mCycle计划使PTV的V33.2平均从手动计划的95.7%提升至97.5%(P < .001)。
  • mCycle计划显著降低直肠V32、V28和V18(P ≤ .004)。
  • mCycle计划机器跳数增加17%、出束时间增加9%(P < .001),优化时间缩短19%(P < .019)。

核心结论

  • 在离线场景下,mCycle被证明是1.5 T MR-Linac上前列腺癌SBRT自动计划的可靠方案。
  • 将mCycle整合入在线工作流程将使使用者从具有挑战性的在线优化任务中解放出来。

研究设计与样本

  • 对10例接受35 Gy(处方剂量Dp)分5次治疗的前列腺癌患者,基于每日磁共振成像扫描的50个自适应计划进行离线从头重新优化。
  • 计划分别由专家计划者手动完成(多准则优化 Fluence map 加手动调整分割)和由mCycle完成(按预先指定的优先级列表通过多准则优化序贯优化目标)。

主要发现

  • mCycle计划改善靶区剂量覆盖,PTV的V33.2通过率平均(±1 SD)从手动计划的95.7%(±1.0%)提升至97.5%(±1.3%)(P < .001)。
  • mCycle计划显著降低直肠V32、V28和V18(P ≤ .004)。
  • 在等效分段数下,mCycle计划机器跳数增加17%、出束时间增加9%(P < .001),优化时间普遍缩短19%(P < .019)。
  • 局部归一化γ(3 mm,3%)通过率(P = .059)和γ(2 mm,2%)通过率(P = .432)可交付性指标无显著差异。

关键数值与推荐

  • 计划批准主要标准:至少95%的PTV接受≥95%的Dp,PTV的V33.2 ≥ 95%。
  • 计划批准主要标准:直肠、膀胱、阴茎球和尿道计划风险体积(即尿道加3 mm各向同性外扩)的最热立方厘米剂量小于Dp(V35 ≤ 1 cm3)。
  • 计划批准主要标准:直肠V32 ≤ 5%、V28 ≤ 10%、V18 ≤ 35%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Adaptive stereotactic body radiation therapy (SBRT) for prostate cancer (PC) by the 1.5 T MR-linac currently requires online planning by an expert user. A fully automated and user-independent solution to adaptive planning (mCycle) of PC-SBRT was compared with user's plans for the 1.5 T MR-linac. METHODS AND MATERIALS: Fifty adapted plans on daily magnetic resonance imaging scans for 10 patients with PC treated by 35 Gy (prescription dose [Dp]) in 5 fractions were reoptimized offline from scratch, both by an expert planner (manual) and by mCycle. Manual plans consisted of multicriterial optimization (MCO) of the fluence map plus manual tweaking in segmentation, whereas in mCycle plans, the objectives were sequentially optimized by MCO according to an a-priori assigned priority list. The main criteria for planning approval were a dose ≥95% of the Dp to at least 95% of the planning target volume (PTV), V33.2 (PTV) ≥ 95%, a dose less than the Dp to the hottest cubic centimeter (V35 ≤ 1 cm3) of rectum, bladder, penile bulb, and urethral planning risk volume (ie, urethra plus 3 mm isotropically), and V32 ≤ 5%, V28 ≤ 10%, and V18 ≤ 35% to the rectum. Such dose-volume metrics, plus some efficiency and deliverability metrics, were used for the comparison of mCycle versus manual plans. RESULTS: mCycle plans improved target dose coverage, with V33.2 (PTV) passing on average (±1 SD) from 95.7% (±1.0%) for manual plans to 97.5% (±1.3%) for mCycle plans (P < .001), and rectal dose sparing, with significantly reduced V32, V28, and V18 (P ≤ .004). Although at an equivalent number of segments, mCycle plans consumed moderately more monitor units (+17%) and delivery time (+9%) (P < .001), whereas they were generally faster (-19%) in terms of optimization times (P < .019). No significant differences were found for the passing rates of locally normalized γ (3 mm, 3%) (P = .059) and γ (2 mm, 2%) (P = .432) deliverability metrics. CONCLUSIONS: In the offline setting, mCycle proved to be a trustable solution for automated planning of PC-SBRT on the 1.5 T MR-linac. mCycle integration in the online workflow will free the user from the challenging online-optimization task.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Naccarato S, Rigo M, Pellegrini R, et al. Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac. Adv Radiat Oncol. 2022. PMID: 35198836. doi:10.1016/j.adro.2021.100865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。